BriaCell Therapeutics Corp. (TSX:BCT)
Canada
· Delayed Price · Currency is CAD 5.17
-0.30 (-5.48%)
At close: Mar 6, 2026
BriaCell Therapeutics Employees
BriaCell Therapeutics had 16 employees as of July 31, 2023. The number of employees increased by 10 or 166.67% compared to the previous year.
Employees
16
Change
10
Growth
166.67%
Revenue / Employee
n/a
Profits / Employee
-2.51M CAD
Market Cap
37.49M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jul 31, 2023 | 16 | 10 | 166.67% |
| Jul 31, 2021 | 6 | 0 | - |
| Aug 1, 2019 | 6 | - | - |
BriaCell Therapeutics News
- 2 days ago - BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting - GlobeNewsWire
- 17 days ago - BriaCell (BCTX) Expands Biologic Cancer Treatments Through New Agreement - GuruFocus
- 17 days ago - BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License - GlobeNewsWire
- 18 days ago - BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer - GlobeNewsWire
- 5 weeks ago - BriaCell Therapeutics (BCTX) Shows Promising Results in Metastatic Breast Cancer Treatment - GuruFocus
- 5 weeks ago - BriaCell Patients' Images Show Regression and Resolution of Metastasized Tumors and Immune Activation - GlobeNewsWire
- 5 weeks ago - BriaCell (BCTX) Reports Promising Phase 2 Survival Data - GuruFocus
- 5 weeks ago - BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients - GlobeNewsWire